Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) shares hit a new 52-week high on Thursday . The stock traded as high as $107.56 and last traded at $107.00, with a volume of 391291 shares traded. The stock had previously closed at $94.86. Wall Street Analyst Weigh In BPMC has been the topic of several […]
Wedbush reissued their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report issued on Friday, Benzinga reports. Wedbush currently has a $110.00 target price on the biotechnology company’s stock. Several other equities analysts have also recently commented on the company. Needham & Company LLC reiterated a buy rating and set […]
Blueprint Medicines (BPMC) Buy Rating Reaffirmed at Needham & Company LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Blueprint Medicines (NASDAQ:BPMC) Earns Buy Rating from HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.